SOFOSBUVIR/VELPATASVIR IS EFFECTIVE AND SAFE IN PATIENTS WITH CONCOMITANT PROTON PUMP INHIBITOR USE IN CLINICAL STUDIES

dc.conference.dateJUN 08-09, 2019
dc.conference.titleInternational Digestive Disease Forum (IDDF)
dc.contributor.authorEsteban, Rafael
dc.contributor.authorAgarwal, Kosh
dc.contributor.authorCalleja, Jose Luis
dc.contributor.authorDufour, Jean-Francois
dc.contributor.authorFlamm, Steven
dc.contributor.authorGordon, Stuart
dc.contributor.authorStamm, Luisa
dc.contributor.authorNi, Liyun
dc.contributor.authorBrainard, Diana
dc.contributor.authorYip, Christina Sze Man
dc.contributor.authorKowdley, Kris
dc.contributor.authorCooper, Curtis
dc.contributor.authorAntonio Pineda, Juan
dc.contributor.authorCastells, Lluis
dc.contributor.authorButi, Maria
dc.contributor.authorLens, Sabela
dc.contributor.authoraffiliation[Esteban, Rafael] Vall dHebron Univ Hosp, Barcelona, Spain
dc.contributor.authoraffiliation[Castells, Lluis] Vall dHebron Univ Hosp, Barcelona, Spain
dc.contributor.authoraffiliation[Buti, Maria] Vall dHebron Univ Hosp, Barcelona, Spain
dc.contributor.authoraffiliation[Agarwal, Kosh] Kings Coll Hosp NHS Trust, London, England
dc.contributor.authoraffiliation[Calleja, Jose Luis] Hosp Univ Puerta Hierro, Madrid, Spain
dc.contributor.authoraffiliation[Dufour, Jean-Francois] Univ Bern, Bern, Switzerland
dc.contributor.authoraffiliation[Flamm, Steven] Northwestern Univ Hlth Syst, Chicago, IL USA
dc.contributor.authoraffiliation[Gordon, Stuart] Henry Ford Hlth Syst, Detroit, MI USA
dc.contributor.authoraffiliation[Stamm, Luisa] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
dc.contributor.authoraffiliation[Ni, Liyun] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
dc.contributor.authoraffiliation[Brainard, Diana] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
dc.contributor.authoraffiliation[Yip, Christina Sze Man] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
dc.contributor.authoraffiliation[Kowdley, Kris] Swedish Med Ctr, Seattle, WA USA
dc.contributor.authoraffiliation[Cooper, Curtis] Ottawa Hosp, Ottawa, ON, Canada
dc.contributor.authoraffiliation[Antonio Pineda, Juan] Hosp Univ Virgen Valme, Seville, Spain
dc.contributor.authoraffiliation[Lens, Sabela] Univ Barcelona, Barcelona, Spain
dc.date.accessioned2025-01-07T15:28:58Z
dc.date.available2025-01-07T15:28:58Z
dc.date.issued2019-06-01
dc.identifier.doi10.1136/gutjnl-2019-IDDFabstracts.268
dc.identifier.essn1468-3288
dc.identifier.issn0017-5749
dc.identifier.unpaywallURLhttps://gut.bmj.com/content/gutjnl/68/Suppl_1/A137.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/27181
dc.identifier.wosID472085300265
dc.issue.number1
dc.journal.titleGut
dc.journal.titleabbreviationGut
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de Valme
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberA137-A137
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleSOFOSBUVIR/VELPATASVIR IS EFFECTIVE AND SAFE IN PATIENTS WITH CONCOMITANT PROTON PUMP INHIBITOR USE IN CLINICAL STUDIES
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number68
dc.wostypeMeeting Abstract

Files